MONTREAL, CANADA--(Marketwired - Feb. 24, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced the hiring of Philippe Dubuc as Senior Vice President and Chief Financial Officer.

"After the first full year of marketing EGRIFTA® on our own in the U.S., we are now entering the next phase of our business strategy. As Senior VP and CFO, Philippe will play a crucial role in increasing our relationships with current and future investors. Equally important, he will lead our efforts in the identification of potential product acquisitions and in-licensing opportunities that could maximize the return on our infrastructure and fit within our distribution network." said Luc Tanguay, President and CEO, Theratechnologies Inc.

"Our Company is well placed to further exploit its infrastructure particularly in the U.S., and also to support the HIV community," added Mr. Tanguay.

Mr. Dubuc brings more than 25 years of experience in investment banking in the healthcare sector and in management. He started his career as a management consultant at Groupe Secor, a well-known Quebec-based consulting firm which is now part of KPMG.

He then served as Managing Director, Investment Banking at National Bank Financial. In this role, he headed the healthcare group and was involved in numerous financing and M&A transactions. He later founded a manufacturing company which he sold after seven years of successful operations.

Mr. Dubuc holds a M.B.A. from McGill University and a B.Comm. from Concordia University.

About Theratechnologies

Theratechnologies (TSX:TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and an improved quality of life. Further information about Theratechnologies is available on the Company's website at and on SEDAR at

Contact Information:

Denis Boucher